Monitor, manage, and communicate with study participants at home.
As part of Best Buy Health, we have the technology, services, and expertise to help drive trial success.
Safety monitoring at home
Adverse event detection
Exploratory endpoint analysis
Digital biomarker development
Support services for technology, monitoring, and logistics
Monitor for safety, prove efficacy, and improve accessibility for your clinical trial.
Safety monitoring and biomarker development.
Prove efficacy of outpatient delivery of therapies in the home.
Enable outpatient delivery of therapies in the home.
With leading technology, wraparound services, and a network of health system partners, we can help you keep patients safe and enrolled in your trial.
Our model involves building an initial version using clinical literature and previous trial data, adapting to known drug and patient cohort risks.
Biomarker inputs can include:
Our consumer-friendly technology can help lower your trial’s barriers to participation.
to set up our kit
patient adherence
patients managed
languages available
Explore our research with Mount Sinai Health System which evaluates the feasibility of reducing hospital stays for patients undergoing CAR-T therapy through the use of safety monitoring in the home.
Our platform is configurable across clinical use cases, enabling custom patient journeys for your trial protocols.
Identify adverse events earlier with our ICU-level continuous monitoring of heart rate, respiratory rate, SpO2, movement, and axillary temperature. Get intelligent alarms based on multiple data points and customise monitoring for each trial.
Our end-to-end platform makes it easy for clinicians to conduct virtual visits and coordinate in-home care. Collect ePro data with scheduled symptom assessments and asynchronous messaging, reducing hospital admissions and keeping patients safely at home.
Support your trial with wraparound experience services. Our 24/7 virtual nurses, technology support, and logistics teams are all fully in-house and can be deployed as part of your trial to ensure excellent experiences for patients, providers, and caregivers.
The CRO enrols Beverley, a new patient into a clinical trial for a new oncology drug.
They are sent a Current Health kit configured to their clinical condition, including the continuous monitoring wearable and a tablet equipped with cellular connectivity.
Current Health monitors the participant through the wearable device and any wirelessly integrated peripheral devices. The data is automatically transmitted straight to the CRO’s EDC vendor and the participant’s care team.
The research team can correlate adverse events with physiological data to better determine causation, as well as identify sub-groups who might derive even more significant benefit from their new drug.
